1-(4-chloro-3-fluorophenyl)-3-[4-(5-methyl-2-pyridinyl)-1,4-diazepan-1-yl]pyrrolidin-2-one;tris(3-[2,2-dimethyl-4-(5-methyl-2-pyridinyl)piperazin-1-yl]-1-[(4-methylphenyl)methyl]pyrrolidin-2-one);4-[1-[(4-fluorophenyl)methyl]-2-oxopyrrolidin-3-yl]-1-(5-methyl-2-pyridinyl)piperazin-2-one;(3R)-1-[(4-methylphenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)-1,4-diazepan-1-yl]pyrrolidin-2-one;1-[1-[(4-methylphenyl)methyl]-2-oxopyrrolidin-3-yl]-4-(5-methyl-2-pyridinyl)piperazin-2-one;4-[1-[(4-methylphenyl)methyl]-2-oxopyrrolidin-3-yl]-1-(5-methyl-2-pyridinyl)piperazin-2-one
C181H225ClF2N32O11 — CID 159536255
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(4-chloro-3-fluorophenyl)-3-[4-(5-methyl-2-pyridinyl)-1,4-diazepan-1-yl]pyrrolidin-2-one;tris(3-[2,2-dimethyl-4-(5-methyl-2-pyridinyl)piperazin-1-yl]-1-[(4-methylphenyl)methyl]pyrrolidin-2-one);4-[1-[(4-fluorophenyl)methyl]-2-oxopyrrolidin-3-yl]-1-(5-methyl-2-pyridinyl)piperazin-2-one;(3R)-1-[(4-methylphenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)-1,4-diazepan-1-yl]pyrrolidin-2-one;1-[1-[(4-methylphenyl)methyl]-2-oxopyrrolidin-3-yl]-4-(5-methyl-2-pyridinyl)piperazin-2-one;4-[1-[(4-methylphenyl)methyl]-2-oxopyrrolidin-3-yl]-1-(5-methyl-2-pyridinyl)piperazin-2-one
1-(4-chloro-3-fluorophenyl)-3-[4-(5-methyl-2-pyridinyl)-1,4-diazepan-1-yl]pyrrolidin-2-one;tris(3-[2,2-dimethyl-4-(5-methyl-2-pyridinyl)piperazin-1-yl]-1-[(4-methylphenyl)methyl]pyrrolidin-2-one);4-[1-[(4-fluorophenyl)methyl]-2-oxopyrrolidin-3-yl]-1-(5-methyl-2-pyridinyl)piperazin-2-one;(3R)-1-[(4-methylphenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)-1,4-diazepan-1-yl]pyrrolidin-2-one;1-[1-[(4-methylphenyl)methyl]-2-oxopyrrolidin-3-yl]-4-(5-methyl-2-pyridinyl)piperazin-2-one;4-[1-[(4-methylphenyl)methyl]-2-oxopyrrolidin-3-yl]-1-(5-methyl-2-pyridinyl)piperazin-2-one (PubChem CID 159536255) has the molecular formula C181H225ClF2N32O11 and a molecular weight of 3098.45 g/mol. Its IUPAC name is 1-(4-chloro-3-fluorophenyl)-3-[4-(5-methyl-2-pyridinyl)-1,4-diazepan-1-yl]pyrrolidin-2-one;tris(3-[2,2-dimethyl-4-(5-methyl-2-pyridinyl)piperazin-1-yl]-1-[(4-methylphenyl)methyl]pyrrolidin-2-one);4-[1-[(4-fluorophenyl)methyl]-2-oxopyrrolidin-3-yl]-1-(5-methyl-2-pyridinyl)piperazin-2-one;(3R)-1-[(4-methylphenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)-1,4-diazepan-1-yl]pyrrolidin-2-one;1-[1-[(4-methylphenyl)methyl]-2-oxopyrrolidin-3-yl]-4-(5-methyl-2-pyridinyl)piperazin-2-one;4-[1-[(4-methylphenyl)methyl]-2-oxopyrrolidin-3-yl]-1-(5-methyl-2-pyridinyl)piperazin-2-one.
Molecular Properties
| Compound Name | 1-(4-chloro-3-fluorophenyl)-3-[4-(5-methyl-2-pyridinyl)-1,4-diazepan-1-yl]pyrrolidin-2-one;tris(3-[2,2-dimethyl-4-(5-methyl-2-pyridinyl)piperazin-1-yl]-1-[(4-methylphenyl)methyl]pyrrolidin-2-one);4-[1-[(4-fluorophenyl)methyl]-2-oxopyrrolidin-3-yl]-1-(5-methyl-2-pyridinyl)piperazin-2-one;(3R)-1-[(4-methylphenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)-1,4-diazepan-1-yl]pyrrolidin-2-one;1-[1-[(4-methylphenyl)methyl]-2-oxopyrrolidin-3-yl]-4-(5-methyl-2-pyridinyl)piperazin-2-one;4-[1-[(4-methylphenyl)methyl]-2-oxopyrrolidin-3-yl]-1-(5-methyl-2-pyridinyl)piperazin-2-one |
|---|---|
| PubChem CID | 159536255 |
| Molecular Formula | C181H225ClF2N32O11 |
| Molecular Weight | 3098.45 g/mol |
| Exact Mass | 3095.77 |
| IUPAC Name | 1-(4-chloro-3-fluorophenyl)-3-[4-(5-methyl-2-pyridinyl)-1,4-diazepan-1-yl]pyrrolidin-2-one;tris(3-[2,2-dimethyl-4-(5-methyl-2-pyridinyl)piperazin-1-yl]-1-[(4-methylphenyl)methyl]pyrrolidin-2-one);4-[1-[(4-fluorophenyl)methyl]-2-oxopyrrolidin-3-yl]-1-(5-methyl-2-pyridinyl)piperazin-2-one;(3R)-1-[(4-methylphenyl)methyl]-3-[4-(5-methyl-2-pyridinyl)-1,4-diazepan-1-yl]pyrrolidin-2-one;1-[1-[(4-methylphenyl)methyl]-2-oxopyrrolidin-3-yl]-4-(5-methyl-2-pyridinyl)piperazin-2-one;4-[1-[(4-methylphenyl)methyl]-2-oxopyrrolidin-3-yl]-1-(5-methyl-2-pyridinyl)piperazin-2-one |
| SMILES | Cc1ccc(CN2CCC(N3CCN(c4ccc(C)cn4)C(=O)C3)C2=O)cc1.Cc1ccc(CN2CCC(N3CCN(c4ccc(C)cn4)CC3(C)C)C2=O)cc1.Cc1ccc(CN2CCC(N3CCN(c4ccc(C)cn4)CC3(C)C)C2=O)cc1.Cc1ccc(CN2CCC(N3CCN(c4ccc(C)cn4)CC3(C)C)C2=O)cc1.Cc1ccc(CN2CCC(N3CCN(c4ccc(C)cn4)CC3=O)C2=O)cc1.Cc1ccc(CN2CC[C@@H](N3CCCN(c4ccc(C)cn4)CC3)C2=O)cc1.Cc1ccc(N2CCCN(C3CCN(c4ccc(Cl)c(F)c4)C3=O)CC2)nc1.Cc1ccc(N2CCN(C3CCN(Cc4ccc(F)cc4)C3=O)CC2=O)nc1 |
| InChI | InChI=1S/3C24H32N4O.C23H30N4O.2C22H26N4O2.C21H24ClFN4O.C21H23FN4O2/c3*1-18-5-8-20(9-6-18)16-26-12-11-21(23(26)29)28-14-13-27(17-24(28,3)4)22-10-7-19(2)15-25-22;1-18-4-7-20(8-5-18)17-27-13-10-21(23(27)28)25-11-3-12-26(15-14-25)22-9-6-19(2)16-24-22;1-16-3-6-18(7-4-16)14-25-10-9-19(22(25)28)26-12-11-24(15-21(26)27)20-8-5-17(2)13-23-20;1-16-3-6-18(7-4-16)14-25-10-9-19(22(25)28)24-11-12-26(21(27)15-24)20-8-5-17(2)13-23-20;1-15-3-6-20(24-14-15)26-9-2-8-25(11-12-26)19-7-10-27(21(19)28)16-4-5-17(22)18(23)13-16;1-15-2-7-19(23-12-15)26-11-10-24(14-20(26)27)18-8-9-25(21(18)28)13-16-3-5-17(22)6-4-16/h3*5-10,15,21H,11-14,16-17H2,1-4H3;4-9,16,21H,3,10-15,17H2,1-2H3;2*3-8,13,19H,9-12,14-15H2,1-2H3;3-6,13-14,19H,2,7-12H2,1H3;2-7,12,18H,8-11,13-14H2,1H3/t;;;21-;;;;/m...1..../s1 |
| InChIKey | MDPYQBZBKTXBOR-NVUYVDNISA-N |
| XLogP | 22.99 |
| TPSA | 368.65 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 227 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3098.45 |
| LogP ≤ 5 | 22.99 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 32 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159536255 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.